Prognostic value of DNA analysis of prostate adenocarcinoma: Correlation to clinicopathologic predictors

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 2, 2005, Pages 273-278

  Bantis, A ^b   Gonidi, M ^b   Athanassiades, P ^b   Tsolos, Ch ^b   Liossi, A ^b   Aggelonidou, E ^b   Athanassiadou, A M ^b   Petrakakou, E ^b   Athanassiadou, Pauline ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

DNA ploidy; Image Analysis; Prognostic factors; Prostate cancer

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE COURSE; DNA DETERMINATION; GLEASON SCORE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; REGRESSION ANALYSIS;

ADENOCARCINOMA; AGED; ANEUPLOIDY; CELL DIFFERENTIATION; DNA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 22844451590     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Shankey T.V., Jin J.K., Doughetry S.: DNA ploidy and proliferation heterogeneity in human prostate cancers. Cytometry 21:30-39, 1995.
2. Sakr W.A., Grignon D.J.: Prostate cancer indications and aggressiveness. Eur. Urol. 32(Suppl 3): 15-23, 1997.
3. Shockley K.F., Maatman T.J., Garothers G.C.: Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of prostate, including DNA ploidy, surgical tumor stage, prostate specific antigen, Gleason grade and age. Prostate 29:46-50, 1996.
4. Auer G.U., Falkmer U.G., Zetterberg A.D.: Image cytometric nuclear DNA analysis in clinical tumor material. In: Baak JPA, ed Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Berlin: Springer-Verlag:pp.218-220, 1991.
5. Epstein J.I., Pizov G., Steinberg G.D.: Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. J. Urol. 148:87-91, 1991.
6. Kavantzas N., Agapitos E., Lazanas A.C.: Nuclear/Nucleolar morphometry and DNA image cytometry as a combined diagnostic tool in pathology of prostatic carcinoma. J. Exp. Clin. Cancer Res. 20(4):537-542, 2001.
7. Wang N., Wilkin C., Bocking A.: Evaluation of tumor heterogeneity of prostate carcinoma by flow and image DNA cytometry and histopathological grading. Anal. Cell. Pathol. 20(1):49-62, 2000.
8. Boore M., Hoyer M., Nerstrom B.: DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure. Prostate 36(4):244-249, 1998.
9. Di Silvero F., D'Eramo G., Buscarini M.: DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy. Eur. Urol. 30(3):316-321, 1996.
10. Athanasiadou P., Kavantzas N., Davaris P.: Diagnostic approach of effusion cytology using computerized image analysis. J. Exp. Clin. Cancer Res. 21:49-56, 2002.
11. Fleming I., Cooper J., Henson D.: AJCC Cancer Staging Handbook, ed 5th Lippincott, Williams & Wilkins, Philadelphia: pp. 203, 1998.
12. Martinez-Jabaloyas J.M., Ruiz-Cerda J.L., Hernadez M.: Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation. Urology 59(5):715-720, 2002.
13. Sebo T.J., Cheviile J.C., Riehle D.L.: Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 91(11):2196-204, 2001.
14. Stege R.H., Tribukait B., Carlstrom K.A.: Tissue PSA from fine needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade and DNA ploidy. Prostate 38(3):183-188, 1999.
15. Brinker D.A., Ross J.S., Tran T.A.: Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade. J. Urol. 162(6):2036-2039, 1999.
16. Green D.R., Taylor S.R., Wheeler T.M.: DNA ploidy by image analysis of individual foci of prostate cancer. Cancer Res. 51:4084-4089, 1991.
17. Partin A., Oesterling J.: The clinical usefulness of prostate specific antigen: update. J. Urol. 152:1358-1368, 1994.
18. Kleer E., and Oesterling J.: PSA and staging of localized prostate cancer. Urol. Clin. N. Amer. 20:695-704, 1993.
19. Carter H.B., and Pearson J.D.: Prostate specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines. Urology 54:780-786, 1999.
20. Shockley K.F., Maatman T.J., Carothers G.C.: Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade and age. Prostate 29(1):46-50, 1996.
21. Deliveliotis C., Skolarikos A., Karayannis A.: The prognostic value of p53 and DNA ploidy following radical prostatectomy World J. Urol.:21(3):171-176, 2003.